documents: FDA-2022-N-2796-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2796-0003 FDA FDA-2022-N-2796 Bristol Myers Products Inc.; Withdrawal of Approval of a New Drug Application for BUFFERIN (Aspirin) Tablets Notice Withdrawal 2023-07-21T04:00:00Z 2023 7 2023-07-21T04:00:00Z   2023-07-21T13:27:39Z 2023-15454 0 0 0900006485cf8e61

Links from other tables